Rescula Discussion

It’s actually old

The FDA approved Rescula in 2000 for the treatment of open-angle
glaucoma and ocular hypertension. The drug was taken off the market in
the United States in 2005 (apparently for commercial reasons). But the
commercialization rights were licensed in 2009 to Sucampo
Pharmaceutials, Inc. Sucampo then submitted a supplemental New Drug
Application to the FDA and relaunched the product.